| D007226 |
Infant Mortality |
Postnatal deaths from BIRTH to 365 days after birth in a given population. Postneonatal mortality represents deaths between 28 days and 365 days after birth (as defined by National Center for Health Statistics). Neonatal mortality represents deaths from birth to 27 days after birth. |
Neonatal Mortality,Mortality, Infant,Postneonatal Mortality,Infant Mortalities,Mortalities, Infant,Mortalities, Neonatal,Mortalities, Postneonatal,Mortality, Neonatal,Mortality, Postneonatal,Neonatal Mortalities,Postneonatal Mortalities |
|
| D007231 |
Infant, Newborn |
An infant during the first 28 days after birth. |
Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants |
|
| D007328 |
Insulin |
A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). |
Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin |
|
| D008076 |
Cholesterol, HDL |
Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. |
High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol |
|
| D008428 |
Maternal Mortality |
Maternal deaths resulting from complications of pregnancy and childbirth in a given population. |
Mortality, Maternal,Maternal Mortalities,Mortalities, Maternal |
|
| D009747 |
Nutritional Physiological Phenomena |
The processes and properties of living organisms by which they take in and balance the use of nutritive materials for energy, heat production, or building material for the growth, maintenance, or repair of tissues and the nutritive properties of FOOD. |
Nutrition Physiological Phenomena,Nutrition Physiology,Nutrition Processes,Nutritional Physiology Phenomena,Nutrition Phenomena,Nutrition Physiological Concepts,Nutrition Physiological Phenomenon,Nutrition Process,Nutritional Phenomena,Nutritional Physiological Phenomenon,Nutritional Physiology,Nutritional Physiology Concepts,Nutritional Physiology Phenomenon,Nutritional Process,Nutritional Processes,Concept, Nutrition Physiological,Concept, Nutritional Physiology,Concepts, Nutrition Physiological,Concepts, Nutritional Physiology,Nutrition Physiological Concept,Nutritional Physiology Concept,Phenomena, Nutrition,Phenomena, Nutrition Physiological,Phenomena, Nutritional,Phenomena, Nutritional Physiological,Phenomena, Nutritional Physiology,Phenomenon, Nutrition Physiological,Phenomenon, Nutritional Physiological,Phenomenon, Nutritional Physiology,Physiological Concept, Nutrition,Physiological Concepts, Nutrition,Physiological Phenomena, Nutrition,Physiological Phenomena, Nutritional,Physiological Phenomenon, Nutrition,Physiological Phenomenon, Nutritional,Physiology Concept, Nutritional,Physiology Concepts, Nutritional,Physiology Phenomena, Nutritional,Physiology Phenomenon, Nutritional,Physiology, Nutrition,Physiology, Nutritional,Process, Nutrition,Process, Nutritional,Processes, Nutrition,Processes, Nutritional |
|
| D011247 |
Pregnancy |
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. |
Gestation,Pregnancies |
|
| D011254 |
Pregnancy in Diabetics |
The state of PREGNANCY in women with DIABETES MELLITUS. This does not include either symptomatic diabetes or GLUCOSE INTOLERANCE induced by pregnancy (DIABETES, GESTATIONAL) which resolves at the end of pregnancy. |
Pregnancy in Diabetes,Pregnancy in Diabete,Pregnancy in Diabetic |
|
| D011263 |
Pregnancy Trimester, Third |
The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation. |
Pregnancy, Third Trimester,Trimester, Third,Last Trimester,Last Trimesters,Pregnancies, Third Trimester,Pregnancy Trimesters, Third,Third Pregnancy Trimester,Third Pregnancy Trimesters,Third Trimester,Third Trimester Pregnancies,Third Trimester Pregnancy,Third Trimesters,Trimester, Last,Trimesters, Last,Trimesters, Third |
|
| D011388 |
Prolactin |
A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. |
Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone |
|
-transparent.png){kind=logo}
